1. An assessment of dose-dependent UV-B sensitivity in Eclipta alba: Biochemical traits, antioxidative properties, and wedelolactone yield
- Author
-
Kshama Rai and Shashi Bhushan Agrawal
- Subjects
chemistry.chemical_classification ,Reactive oxygen species ,Ayurvedic medicine ,Traditional medicine ,Plant Extracts ,Ultraviolet Rays ,Health, Toxicology and Mutagenesis ,Dose dependence ,Eclipta alba ,Eclipta ,General Medicine ,010501 environmental sciences ,Biology ,Photosynthesis ,Wedelolactone ,01 natural sciences ,Pollution ,Antioxidants ,chemistry.chemical_compound ,chemistry ,Coumarins ,Yield (chemistry) ,Environmental Chemistry ,Ecotoxicology ,0105 earth and related environmental sciences - Abstract
The UV-B-induced signals play a crucial role in improving the analeptic values of medicinally important plants. Eclipta alba L. (Hassak), commonly known as False Daisy, holds supreme stature with its pharmaceutical association in treating various ailments, particularly in Ayurvedic medicine. The present study aimed to evaluate the response of E. alba plants exposed to ambient (AT) and two different supplemental UV-B doses (eUV-B, ambient ±7.2 kJ m-2 day-1), i.e., intermittent (IT) and continuous (CT) UV-B treatment for 130 and 240 h respectively. Antioxidative activities and medicinally important compounds (wedelolactone) were measured in different plants' parts at three growth stages. Under both the eUV-B treatments, the photosynthetic pigments were adversely affected (along with reductions in protein content) with a concomitant increase in secondary metabolites. Substantial variations in enzymatic antioxidants and non-enzymatic compounds showed the adaptive resilience strategies of plants against eUV-B. The wedelolactone content increased in leaves but compromised in stem and roots under IT. The results concluded that IT UV-B exposure led to the improvement of plant growth and the yield of wedelolactone compared to CT, suggesting its ameliorative role in improving the test plant's medicinal value.
- Published
- 2021